首页> 外国专利> CONFORMITY OF MORPHINAN AND ANTI-MEDICAL UNIONS FOR THE MARKETING OF THE FORMAL SYSTEM

CONFORMITY OF MORPHINAN AND ANTI-MEDICAL UNIONS FOR THE MARKETING OF THE FORMAL SYSTEM

机译:形态系统和抗医学联盟在规范系统营销中的整合

摘要

They are given in this formulation which includes a dextromorphine analogue according to Type I or Type II or a pharmacologically acceptable salt thereof,each of the former,and a co-factor,e.g.,an antidepressant such as a norepinephrine serotonin reuptake inhibitor,a serotonin dopamine reuptake inhibitor,a norepinephrine dopamine reuptake inhibitor,a monoamine oxidase inhibitor,a selective serotonin reuptake inhibitor and a tricyclic antidepressant or a medically acceptable salt of any of the above. Compositions are useful in treating the pseudochromatic emotion,neuropathic pain,neurodegenerative diseases,brain injuries and the like.
机译:它们以该制剂的形式提供,包括前者I型或II型的右旋吗啡类似物或其药理学上可接受的盐,以及辅因子,例如抗抑郁药,例如去甲肾上腺素5-羟色胺再摄取抑制剂,5-羟色胺多巴胺再摄取抑制剂,去甲肾上腺素多巴胺再摄取抑制剂,单胺氧化酶抑制剂,选择性5-羟色胺再摄取抑制剂和三环抗抑郁药或上述任何一种的医学上可接受的盐。该组合物可用于治疗假色情感,神经性疼痛,神经退行性疾病,脑损伤等。

著录项

  • 公开/公告号CY1117760T1

    专利类型

  • 公开/公告日2017-05-17

    原文格式PDF

  • 申请/专利权人 CONCERT PHARMACEUTICALS INC.;

    申请/专利号CY201611000622T

  • 发明设计人 THOMAS AMANDA;

    申请日2016-07-05

  • 分类号A61K45/06;A61K31/135;A61K31/137;A61K31/138;A61K31/15;A61K31/343;A61K31/4525;A61K31/485;A61P25;

  • 国家 CY

  • 入库时间 2022-08-21 13:39:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号